AbuMoussa Samuel, White Charles Cody, Eichinger Josef K, Friedman Richard J
Department of Orthopaedics and Physical Medicine, Medical University of South Carolina, Charleston, South Carolina.
College of Medicine, Medical University of South Carolina, Charleston, South Carolina.
J Knee Surg. 2019 Aug;32(8):714-718. doi: 10.1055/s-0039-1683979. Epub 2019 Apr 8.
All-polyethylene tibial (APT) implants were incorporated into the initial design of the first total knee arthroplasty (TKA) systems. Since then, a dynamic shift has taken place and metal-backed tibial (MBT) implants have become the gold standard in TKA. This has mostly been due to the theoretical advantages of intraoperative flexibility and improved biomechanics in addition to the heavy influence of device manufacturers. MBT implant comes not only with a higher cost but also with potential for complications such as osteolysis, backside wear, and thinning of the polyethylene insert, which were not previously seen with APT implant. The majority of studies comparing APT and MBT implants have shown no difference in clinical outcomes and survivorship. Newer studies from the past decade have begun highlighting the economic advantages of APT implant, especially in patients undergoing primary, uncomplicated TKA. Use of APT implants in younger patients and those with a body mass index > 35 has not been extensively studied, but the existing literature suggests the use of APT implant in these cohorts to be equally as acceptable. With modern implant design and instrumentation, rising utilization of TKA along with current and future economic strain on health care, the increased use of APT implant could result in massive savings without sacrificing positive patient outcomes.
全聚乙烯胫骨(APT)植入物被纳入了首个全膝关节置换术(TKA)系统的初始设计中。从那时起,情况发生了动态变化,金属背衬胫骨(MBT)植入物已成为TKA的金标准。这主要归因于术中灵活性和生物力学改善的理论优势,以及设备制造商的重大影响。MBT植入物不仅成本更高,还存在诸如骨溶解、背面磨损和聚乙烯衬垫变薄等并发症的可能性,而APT植入物以前并未出现这些问题。大多数比较APT和MBT植入物的研究表明,临床结果和生存率没有差异。过去十年的最新研究开始强调APT植入物的经济优势,尤其是在接受初次、无并发症TKA的患者中。在年轻患者和体重指数>35的患者中使用APT植入物尚未得到广泛研究,但现有文献表明在这些人群中使用APT植入物同样是可以接受的。随着现代植入物设计和器械的发展,TKA的利用率不断提高,以及当前和未来医疗保健面临的经济压力,增加APT植入物的使用可能会在不牺牲患者良好预后的情况下大幅节省成本。